DSOs drove roughly 70% of disclosed dental transactions above $2M practice value in 2025. Heartland, Aspen, Pacific Dental, Smile Brands, MB2 Dental and the specialty consolidators are still actively deploying capital, but the runway is finite. The dentists getting top-quartile multiples in 2027 documented their hygiene production, associate depth, and patient retention in 2026.
Start with a 15-minute call · NDA first · no prep neededThe practices selling at top-quartile multiples are the ones whose hygiene production and associate depth were intentionally built three years before listing.
DSO buyer balance sheets are still hungry but increasingly selective. Heartland Dental, Aspen, Pacific Dental Services, Smile Brands, MB2 Dental, Sage Dental — they paid premium for high-quality practices in 2024-2025 and are now demanding more proof of clinical depth, patient retention, and operational independence from the founding dentist. The general practices commanding top-quartile multiples in 2026 share three things: documented hygiene production above 25% of revenue, multi-doctor depth where no single dentist generates more than 50% of production, and PPO/FFS mix above 60% with low insurance write-off ratios.
Five active buyer categories:
Three biggest discount factors. Solo-dentist concentration above 50% of production. Recently lost associates with no replacement plan. Insurance write-off ratio above 25% (signals undermarketed PPO contracts or unfavorable insurance mix). All three are fixable but require 12-24 months of intentional work.
The dentists who get strong multiples in the next three years built their practice to operate without them for 60+ days at a time. Solo practitioners who want top quartile have the longest runway — reducing solo-doctor concentration to under 50% of production typically takes 18-36 months of intentional associate hiring and retention.
Heartland Dental, Aspen Dental, Pacific Dental Services, Smile Brands, MB2 Dental, Affordable Care, Sage Dental, Western Dental. Most active acquirers of $2M+ practices. Pay top of market for multi-doctor depth, hygiene production, and clean PPO/FFS mix.
US Oral Surgery Management, OrthoSynetics, Pediatric Dental Brands, Specialty Dental Brands. Pay premium multiples for specialty practices with strong production per provider and defensible referral relationships. Often the right fit for ortho, oral surgery, perio, endo, and pediatric.
Most active sub-$1.5M practice value, where SBA financing supports clean acquisitions. Lower headline price than DSOs but cleaner continuity and faster close. Useful as floor-setters in an auction at the lower end.
Multi-location regional groups running tuck-in acquisitions to expand footprint. Closes typically faster than DSO processes. Lower headline multiples but better cultural integration and stronger associate retention.
Episodic at the larger end ($5M+ practices). Sometimes invest passively in DSO platforms; occasionally buy individual practices to start a regional roll-up. Highly idiosyncratic but worth approaching when fit is obvious.
Existing associate dentists, partners, or family members buying out the founder. Cleanest continuity but typically lowest gross proceeds. Best when paired with seller financing or partial recap to a DSO for liquidity.
We review last 24 months of production by provider, hygiene production, insurance mix (FFS, PPO, HMO/DMO, Medicaid), patient retention metrics, associate depth, and write-off ratios. Output: a written valuation memo with comps from disclosed DSO and specialty consolidator transactions in your geography and subspecialty.
Outreach to DSOs, specialty consolidators, independent dentists, strategic group practices, and family offices simultaneously, under NDA before any public listing. The auction process is what gets DSO buyers to compete on price rather than dictating terms.
Management Service Agreement structure (where state CPD rules require), associate employment agreement transitions, non-compete enforceability state-by-state, and earnout structures get sequenced alongside PSA negotiation. The dental-specific work happens with dental-specialized counsel.
General dentistry single-location practices trade at 65-85% of trailing-12-month collections, or 4-6× SDE. Multi-doctor general groups clear 6-9× EBITDA. Specialty practices (ortho, oral surgery, endo, perio, pediatric) trade at 6-11× EBITDA depending on subspecialty and DSO buyer interest. Top of range goes to multi-doctor practices with documented hygiene production, low solo-doctor concentration, and FFS or PPO mix above 60%.
12-24 months before close. The work that drives multiple — recruiting and retaining associates, documenting hygiene production, building patient retention metrics, cleaning up insurance write-off ratios — takes that long. Solo dentists planning to exit need the longest runway because reducing solo-doctor concentration is the single hardest valuation lever.
Five buyer categories. DSOs (Heartland Dental, Aspen Dental, Pacific Dental Services, Smile Brands, MB2 Dental, Affordable Care, Sage Dental, Western Dental). Specialty consolidators (US Oral Surgery Management, OrthoSynetics, Pediatric Dental Brands, Specialty Dental Brands). Independent dentist buyers (especially below $1.5M practice value). Strategic group practices running tuck-ins. Family offices and private investors at the larger end. DSOs drive ~70% of disclosed transactions above $2M practice value.
DSOs typically pay higher headline multiples but require longer earnout periods (3-5 years), tie compensation to production, and integrate the practice into their management infrastructure. Independent dentist buyers pay lower upfront but offer cleaner operational continuity and faster closes. The right buyer type depends on whether you want to keep practicing for 3-5 years post-sale and whether you value gross proceeds or simplicity more.
Hygiene production is one of the cleanest signals of practice quality. Practices where hygiene drives 25-35% of revenue with high case acceptance score significantly higher than practices where hygiene is purely a recall function. Buyers will pull last 24 months of hygienist production by provider and patient retention rates within hygiene specifically. Strong hygiene production also reduces solo-doctor concentration risk.
Associate retention is the second-largest deal-killer in dental M&A after solo-doctor concentration. Most DSO deals require associates to sign new employment agreements with the buyer prior to closing — and associates with portable patient relationships often use the deal as a moment to renegotiate their comp. Plan associate communication and retention bonuses 60-90 days before LOI signing.
Non-compete enforceability varies by state and has gotten weaker in several jurisdictions over the last 36 months. Buyers will require sellers and key associates to sign new non-competes at closing. The geographic radius and time period get heavily negotiated. In states where non-competes are weaker (California, North Dakota, Oklahoma, parts of Minnesota), buyers structure earnouts and non-solicit provisions to compensate.
State Corporate Practice of Dentistry (CPD) rules vary widely. Some states restrict non-dentist ownership, which is why DSO structures use management service agreements (MSAs) where the dentist remains the legal practice owner and the DSO provides management services. The MSA structure has to comply with state law in every state where the practice operates. We coordinate with dental-specialized counsel on the MSA structure during diligence.
8-12 months from engagement to close for DSO transactions. Independent dentist buyer transactions can close in 4-6 months. Pre-engagement preparation (associate retention work, hygiene production documentation, insurance contract review) is separate. The deal itself: 4-6 weeks of CIM and outreach, 4-8 weeks of LOI and clinical/financial diligence, 6-10 weeks from PSA to close.
Two differences. We use proprietary data infrastructure to surface qualified buyers across all five categories simultaneously, not the 6-10 names a regional dental broker keeps in their rolodex. And we represent owners exclusively — never buyers — so when we negotiate, our incentive isn't split between getting your deal closed and keeping a buyer relationship for next year.
No prep on your end. NDA before any specifics get discussed. The output is a written valuation range based on your production mix, hygiene metrics, associate depth, and buyer-pool fit — not a sales pitch.
Request a confidential conversation